Like Wu MD, PhD, Managing Director
Dr. Wu is the Managing Director of the Center. He is one of the China's most distinguished neurologists since 1985 when he first started as a resident at one of China's top domestic facilities, the Beijing Union Hospital. He had followed Professor Feng Yingkun, the initiator of our native Neurology Science and an expert of neurology, Professor Liu Xiuqin. In 1994, Dr. Wu had further study of neurology, cardiology and general medicine at the instruction of Professor Liu Lisheng and Professor Pan Yingfu in Beijing Fuwai Hospital and Friendship Hospital. He achieved a PhD of Medical Sciences from Hebei Medical University in 2005. He worked with his Director, Professor Wang Mingwei and complete the project "bone marrow stromal stem cell implantation treat Parkinson's Disease", the project won the second prize of "Hebei scientific and technological progress". Dr. Like Wu has a deep understanding in treatment of cerebrovascular disease, seizure, dementia, vertigo and headache. He also practices general internal medicine and cardiology. Dr. Wu mastered the skill of neural stem cell's pure culture and identification. In recent years, he devoted himself in the research of autologous stem cell activation treatment for cerebrovascular disease and stem cell implantation to treat Parkinson's disease and ALS. He has published more than 30 research articles and he has contributed to the writing of many medical works. His project "neural stem cell activation technology post cerebral ischemia" won the Natural Science Foundation Award of Hebei Province. Dr. Wu is a member of the Chinese Medical Doctors Association, Chinese Physicians Association, World Brilliant Chinese Association and the Distinguished Researcher of China Science Management Committee.
Education:
2002-2005: PhD of Medical Sciences: Hebei Medical University.
1999-2002:MSC of Medical Sciences: Hebei Medical University.
1980-1985: Degree of Medicine: Capital University of Medical Science.
Work Experience:
2008-Present: Wu Stem Cells Medical Centre: Managing Director and Head Neurologist .
2005-2008: Beijing Tiantan Puhua Hospital: Director of Neurology Department .
1987-2005: Affiliated Central Hospital of Tianjin Medical University: Attending Neurologist
1985-1987: Beijing Union Hospital: Resident Neurologist.
Research Experience:
2007: Clinical study with two types of stem cells to treat Parkinson's disease. major project of Beijing's Science and Technology Commission.
2002-2005: Clinical study and industrialization of stem cells, special major project of Beijing Science Commission.
Memberships:
Member of the Chinese Medical Doctors Association.
Chinese Medical Association.
World Brilliant Chinese Association.
Prizes and Awards:
Hebei Province Natural Science Foundation.
Hebei Province Planning Foundation.
Publications:
1. Research progress of bone marrow stromal cells in the treatment of Parkinson's disease. Like Wu and Xiaoxjian Wang. Overseas Medicine, Elderly Medicine (fascicule of overseas medicine). 008, 29(4):181-184
2. Having the chance to use stem cells to treat injuries of spinal cord sequela. Like Wu and Xiaoxjian Wang, health report, 2006, (9), No 4
3. Aminoguanidine of NOSI can protect the cerebral ischemia of rats. Chinese Clinical Medicine Research Magazine. Like Wu, Chen Chen, Xiaoxjian Wang. 2006,26(6): 1-3
4. MPO and NSE's active change in the brain of rats with cerebral ischemia. Like Wu, Zhou Zhang, Xiaoxjian Wang. Beijing medicine, 2006,28(8):35-37
5. New strategy in the use of stem cells to treat cerebrovascular disease sequela. Like Wu and Xiaoxjian Wang, Healthy Newspaper, 2005 12, No 4
6. Effects of TNF post-receptor reaction to cerebral cysticerosis. Like Wu, Xiaojuan Wang, et al. Basic and Clinical Medicine, 2005 25(3) 265-267
7. Level of endometrial estrogea receptor, plasma estradiol and morphological changes after tubal ligation in rats. Chaoquan Wei, Huchang Zheng, Like Wu. Chinese Journal of Practical Medicine 2002, Vol. 4 No 9 17-20
8. Guidelines for the management of patients with acute ischemic stroke. Like Wu. The Journal of Hypertension.
9. Mitochondrial Encephalomypathy - Chronic Progressive External Ophalmolegia syndrome. Like Wu, Huang Yixin. The Journal of Brain and Neurological Disease, 1996 Vol. 4 No 6-10
10. NO and Epilepsy research progress. Like Wu, et al. Henan Practical Neurological Journal, 2003 Vol. 6 No 2
11. Practical value of SEP and SNAP in the diagnosis of Brachial Plexus (Preganlionic or postganglionic) injury. Like Wu, Yi Xing Huang, et al. Modern Electricity Physiology Journal
12. The MPO level changes of ischemia reperfusion injury in rats. Like Wu, Xueming Sheng. The Journal of Brain and Neurological Disease, 2002 Vol. 10 No2
Xiaojuan Wang, MD, PhD
Dr. Wang is Associate Director and the Head Neurologist of the WSCMC. She is one of the China's most experienced researchers of stem cell treatment technology. She has learned from Professor Li Chunyan, the only neurology science academician in China and an expert of cerebrovascular disease. Dr. Wang has successfully treated cerebrovascular disease, neuro-degenerative diseases (such as Parkinson's Disease, dementia, etc), and demyelinating diseases (such as MS, optic neuritis, etc). Dr. Wang has rich experience of the stem cell treatment for brain injury and spinal cord injury. She has done the research work for the Hebei Natural Science Foundation project "Establishment of Organotypic Culture Model of Spinal Cord for Amyotrophic Lateral Sclerosis" and for another project "Effect of Estrogen on Neural Stem Cell's Proliferation and Differentiation Post Cerebral Ischemia". Dr. Wang has done research in the area of motor neuron disease and brain protection therapy post cerebral ischemia in collaboration with Johns Hopkins University (USA). She has published more than 40 research articles on diabetes, cardiac and cerebral vascular diseases as well as on treating patients in crisis situations. Dr. Wang is a member of the Chinese Medical Association, China Physicians Association, World Brilliant Chinese Association, and the Distinguished Researcher of China Science Management Committee.
Education:
2001-2004: PhD of Medical Science: Hebei Medical University.
1999-2001: Masters Degree of Medicine:Capital University of Medical Science.
1989-1994: Degree of Medicine: Nanjing Medical University.
Work Experience:
2008-Present: Wu Stem Cells Medical Centre: Director of Neurology Department.
2005-2008: Beijing Tiantan Puhua Hospital: Director of Neurology Department.
2004-2005: Beijing Tong Ren Hospital: Attending Neurologist.
1994-2004: Affiliated Central Hospital of Tianjin Medical University:Resident and attending Neurologist
Research Experience:
2007- Clinical study with two types of stem cells to treat Parkinson's disease.
Major project of Beijing's Science and Technology Commission.
2002-2005: Clinical study and industrialization of stem cells. Special major project. Beijing's Science Commission.
2001-2004: Stem cell and neurological degeneration diseases.
1998-2001: Cerebral Ischemia and brain injury .
Memberships:
Member of the Chinese Medical Doctors Association.
Chinese Medical Association .
World Brilliant Chinese Association.
Prizes and Awards:
Hebei Province Natural Science Foundation.
Hebei Province Planning Foundation.
Books: Neurology
Diabetes, Cardiac and Cerebral Vascular Diseases.
The Treatment of Emergency and Crisis Patients.
Papers Published:
1. Research progress of bone marrow stromal cells for the treatment of Parkinson's disease. Like Wu and Xiaoxjian Wang. Overseas Medicine, Elderly Medicine (fascicule of overseas medicine). 008,29(4):181-184.
2. Having the chance to use stem cells to treat injuries of spinal cord sequela. Like Wu and Xiaoxjian Wang, Health Report, 2006, (9), No 4.
3. Aminoguanidine of NOSI can protect the cerebral ischemia of rats. Chinese Clinical Medicine Research Magazine, Like Wu, Chen Chen, Xiaoxjian Wang. 2006,26(6): 1-3.
4. MPO and NSE's active change in the brain of rats with cerebral ischemia. Like Wu, Zhou Zhang, Xiaoxjian Wang, Beijing Medicine, 2006,28(8):35-37.
5. New strategy in the use of stem cells to treat cerebrovascular disease sequela. Like Wu and Xiaoxjian Wang, Healthy Newspaper, 2005 12, No 4.
6. Effects of GDNF on the survival and axon growth of dorsal root ganglion neurons of rats in vitro. Xiaojuan Wang, Guo Li, Liqin Wang, et al. Basic Medical Sciences and Clinics. 2003,123 (6) 629-634.
7. Effects of Glutamate Transport Inhibitor on organotypic cultured spinal cord splice. Xiaoxjian Wang, et al. Acta Biologiae Experimentalis Sinica, 2005 vol. 38 171-176.
8. Establishment of Organotypic Culture Model of Spinal Cord for Amyotrophic Lateral Sclerosis, Weigang Liu, Xiaojuan Wang, et al. Chinese Journal of Cell Biology 2004 ,26: 635-639.
9. A study of organotypic spinal cord splice culture and histochmical identification. Wang Xiaojuan, Song Xueqin, et al. Beijing Medicine (27) 162-166.
10. NO and Epilepsy research progress. Like Wu, et al. Henan Practical Neurological Journal, 2003 Vol. 6 No 2.
11. Practical value of SEP and SNAP in the diagnosis of Brachial Plexus (Preganlionic or postganglionic) injury. Like Wu, Yi Xing Huang, et al. Modern Electricity Physiology Journal.
12. The MPO level changes of ischemia reperfusion injury in rats. Like Wu, Xueming Sheng. The Journal of Brain and Neurological Disease, 2002 Vol. 10 No2.
Our Consultants:
Yonglian Zhu, MD, Professor
Chief of Neurorehabilitation Department at Chinese Rehabilitation Research Center. He had been the director of Beijing Neurosurgery Research Institute. Editor of Chinese Journal of Physical Medicine and Rehabilitation, he is the member of editorial board of Chinese Journal of Neurology.
Xiuqin Liu, MD, Professor.
She has been the Director of Neurology Department of Peking Union Medical College Hospital. Member of Chinese Medical Association. Editor of Chinese Journal of Neurology and Journal of Modern Electrophysiology.
Zhuo Zhang, MD, Professor
He is Director of Neurology Department of Peking Anzhen Hospital. Deputy Director of Neurology Section of Capital University of Medical Sciences. Subeditor of Beijing Journal of Medicine.
Huafeng Yu, MD, Master Tutor
He is director of Neurology Department of Beijing Tongren Hospital, Deputy Director of the fourth Neurology Section of Capital University of Medical Sciences.
Tianfeng Chen, MD
He has been Director of Neurology Department of Beijing Chaoyang Hospital, member of Beijing Neurology Institute of Chinese Medical Association (CMA). Editor of Journal of Cerebrovascular Diseases.
Mingwei Wang,MD, Professor
He is Deputy President of The First Affiliated Hospital of Hebei Medical University, Director of Neurology Department. Director of Neural Stem Cell Research Center of Hebei Medical University. Post Doctorate of University of Pittsburgh USA. He is chairman of Hebei Gerontology Institute.
